Company · CIK 0001626199
ALPINE IMMUNE SCIENCES, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AALPINE IMMUNE SCIENCES, INC.0001172661-24-005283 · 109.5 KBSEC(opens sec.gov)
- SC 13D/AALPINE IMMUNE SCIENCES, INC.0001104659-24-063883 · 81.4 KBSEC(opens sec.gov)
- SC 13D/AALPINE IMMUNE SCIENCES, INC.0001193125-24-143527 · 177.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-142285 · 361.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001626199-24-000064 · 5.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001626199-24-000063 · 247.3 KBSEC(opens sec.gov)
- SC 13D/AALPINE IMMUNE SCIENCES, INC.0001104659-24-054965 · 111.0 KBSEC(opens sec.gov)
- SC 13D/AALPINE IMMUNE SCIENCES, INC.0001193125-24-123019 · 244.0 KBSEC(opens sec.gov)
- 10-K/AALPINE IMMUNE SCIENCES, INC.0001626199-24-000059 · 816.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-091936 · 931.6 KBSEC(opens sec.gov)
Insiders
- Alpine ImmunoSciences, L.P.10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- Carruthers R MichaelInterim President / CFO
- Congleton JonDirector, President and CEO
- CONWAY ROBERT EDirector
- Cui XiangminDirector, 10% Owner
Tickers
No tickers on record.
Addresses
business
188 EAST BLAINE ST., SUITE 200
SEATTLE, WA, 98102
mailing
188 EAST BLAINE ST., SUITE 200
SEATTLE, WA, 98102
Former names
- Nivalis Therapeutics, Inc.2017-07-25
- N30 Pharmaceuticals, Inc.2014-11-25
Same industry